Pasithea Therapeutics (KTTA) Return on Assets (2021 - 2024)
Historic Return on Assets for Pasithea Therapeutics (KTTA) over the last 4 years, with Q3 2024 value amounting to 0.59%.
- Pasithea Therapeutics' Return on Assets fell 5500.0% to 0.59% in Q3 2024 from the same period last year, while for Sep 2024 it was 0.59%, marking a year-over-year decrease of 5500.0%. This contributed to the annual value of 0.01% for FY2023, which is 300.0% up from last year.
- Per Pasithea Therapeutics' latest filing, its Return on Assets stood at 0.59% for Q3 2024, which was down 5500.0% from 0.39% recorded in Q2 2024.
- In the past 5 years, Pasithea Therapeutics' Return on Assets ranged from a high of 0.01% in Q3 2022 and a low of 0.59% during Q3 2024
- In the last 4 years, Pasithea Therapeutics' Return on Assets had a median value of 0.05% in 2022 and averaged 0.12%.
- Per our database at Business Quant, Pasithea Therapeutics' Return on Assets soared by 300bps in 2023 and then tumbled by -5500bps in 2024.
- Quarter analysis of 4 years shows Pasithea Therapeutics' Return on Assets stood at 0.06% in 2021, then increased by 19bps to 0.05% in 2022, then surged by 66bps to 0.02% in 2023, then plummeted by -3602bps to 0.59% in 2024.
- Its Return on Assets stands at 0.59% for Q3 2024, versus 0.39% for Q2 2024 and 0.17% for Q1 2024.